結核薬ベダキリンに結合するミコバクテリアのATP合成の構造
Hui Guo1,2, Gautier M Courbon1,2, Stephanie A Bueler1
1Molecular Medicine Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Nature
|December 10, 2020
まとめ
結核の治療には抗生物質耐性があります 新しい研究により,耐性結核の重要な薬であるベダキリンが,Mycobacterium tuberculosis ATP合成酵素に正確に結合し,眠っている細菌に対するその強力なメカニズムの新たな理解を可能にしました.
科学分野:
- 生物化学
- 微生物学
- 構造生物学
背景:
- 結核 (TB) は感染性疾患の主要な殺手であり,抗生物質耐性の上昇により効果的な治療が脅かされています.
- Mycobacterium tuberculosisは 休眠状態に入り, 低エネルギー状態で生き残ることで 抗生物質を回避します
- ベダキリンは多剤耐性および広範囲耐性結核の治療に不可欠ですが,ATP合成への結合メカニズムは不明でした.
研究 の 目的:
- Mycobacterium tuberculosis ATP合成に対するベダキリンの作用の構造的基礎を解明する.
- ベダキリンがM. tuberculosisに欠かせないATP合成酵素を阻害する方法を理解する.
主な方法:
- Mycobacterium smegmatisのATP合成の冷凍電子顕微鏡構造を決定した.
- 酵素の単体構造と,ベダキリンの複合体で得られた.
主要な成果:
- 無薬のATP合成構造はαサブユニットに阻害的なフックのような拡張を明らかにし,逆機能を防止し,低酸素状態でエネルギーを保存しました.
- ベダキリンの結合は,ATP合成の有意な形状変化を誘導した.
- これらの変化により,A/Cサブユニットのインターフェイスに特定の緊密な結合ポケットが形成され,ベダキリンの高い効能が説明されます.
結論:
- 構造的な洞察は,眠っているM.結核に対するベダキリンの有効性を説明します.
- この結合メカニズムの理解は 新しい抗結核薬の開発に役立つでしょう
- ベダキリンのATP合成との相互作用は,耐性結核と戦うための重要な標的を強調しています.
関連する概念動画
ATP Synthase: Structure
14.3K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
14.3K
ATP Synthase: Mechanism
16.0K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.0K
Pulmonary Tuberculosis V
330
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
330
Bacterial Phylum Actinobacteria
342
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
342
Drugs that Stabilize Microtubules
2.4K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Allosteric Proteins-ATCase
6.2K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.2K


